| 2026-08-06 | 10-Q | 10.3 | License Agreement by and between Aligos Therapeutics, Inc. and Xiamen Amoytop Biotech Co., Ltd. |
|---|
| 2026-06-26 | 8-K | 10.1 | Amendment to the Aligos Therapeutics, Inc. 2020 Employee Stock Purchase Plan. |
|---|
| 2026-05-07 | 10-Q | 10.1 | Non-Employee Director Compensation Policy |
|---|
| 2025-08-06 | 10-Q | 10.3 | Form of Change of Control Severance Agreement |
|---|
| 2025-06-26 | 8-K | 10.1 | Amendment to the Aligos Therapeutics, Inc. 2020 Incentive Award Plan. |
|---|
| 2025-05-06 | 10-Q | 10.1 | Non-Employee Director Compensation Program |
|---|
| 2025-03-10 | 10-K | 10.20 | Letter Agreement, by and among the Company and the investors party thereto. |
|---|
| 2025-03-10 | 10-K | 10.19 | Lead Investor Registration Rights Agreement, by and among the Company and the investors party thereto. |
|---|
| 2025-03-10 | 10-K | 10.18 | Registration Rights Agreement, dated February 13, 2025, by and among the Company and the investors party thereto. |
|---|
| 2025-02-12 | 8-K | 10.4 | Form of Letter Agreement. |
|---|
| 2025-02-12 | 8-K | 10.3 | Form of Lead Investor Registration Rights Agreement. |
|---|
| 2025-02-12 | 8-K | 10.2 | Form of Registration Rights Agreement. |
|---|
| 2025-02-12 | 8-K | 10.1 | Securities Purchase Agreement, dated February 11, 2025, by and among the Company and the Purchasers. |
|---|
| 2024-11-06 | 10-Q | 10.3 | Non-Employee Director Compensation Policy |
|---|
| 2024-11-06 | 10-Q | 10.2 | Employment Agreement by and between Aligos Therapeutics, Inc. and Hardean Achneck, MD, effective as of September 4, 2024 |
|---|
| 2024-11-06 | 10-Q | 10.2 | PDF COURTESY COPY |
|---|
| 2024-11-06 | 10-Q | 10.1.A | 2024 Employment Inducement Award Plan. |
|---|
| 2024-11-06 | 10-Q | 10.1.B | Form of Stock Option Grant Notice and Stock Option Agreement. |
|---|
| 2024-11-06 | 10-Q | 10.1.C | Form of Restricted Stock Unit Award Grant Notice and Restricted Stock Unit Award Agreement. |
|---|
| 2024-08-06 | 10-Q | 10.1 | Non-Employee Director Compensation Policy. |
|---|
| 2024-06-28 | 8-K | 10.1 | Amendment to the Aligos Therapeutics, Inc. 2020 Incentive Award Plan. |
|---|
| 2024-03-12 | 10-K | 10.18 | Separation and release agreement with Leonid Beigelman |
|---|
| 2024-03-12 | 10-K | 10.17 | Amended and Restated Employment Agreement, effective as of December 1, 2020, by and between the Company and Lesley Calhoun |
|---|
| 2024-03-12 | 10-K | 10.16 | Lease Agreement between 601 & 651 GATEWAY CENTER LP and ALIGOS THERAPEUTICS, INC., dated December 9, 2021 |
|---|
| 2023-10-25 | 8-K | 10.1 | Form of Securities Purchase Agreement, dated October 23, 2023, by and among the Company and the Purchasers |
|---|
| 2022-03-10 | 10-K | 10.16 | Lease Agreement between 601 & 651 GATEWAY CENTER LP and ALIGOS THERAPEUTICS, INC., dated December 9, 2021 |
|---|
| 2021-08-05 | 10-Q | 10.1 | Consulting agreement by and between Aligos Therapeutics, Inc. and Kathleen Glaub, dated June 17, 2021. |
|---|
| 2021-05-10 | 10-Q | 10.4 | Form of Change in Control and Severance Agreement. |
|---|
| 2021-05-10 | 10-Q | 10.3 | Employment Agreement by and between Aligos Therapeutics, Inc. and Julian Symons, D.Phil., effective as of May 14, 2019 |
|---|
| 2021-05-10 | 10-Q | 10.2 | Amended and Restated Employment Agreement, effective as of February 10, 2021, by and between the Company and Lawrence M. Blatt. |
|---|
| 2021-05-10 | 10-Q | 10.1 | Amended and Restated Employment Agreement, effective as of February 10, 2021, by and between the Company and Leonid Beigelman. |
|---|